EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED IMMUNE THERAPY

摘要

The disclosure relates among other to a method for the treatment of an individual suffering from a chronic infection by a pathogen and/or a tumor, said method comprising providing the individual in need thereof with antigen of said pathogen or tumor, said method further comprising administering an EGF-R inhibitor and/or a high affinity EGF-R signalling ligand to said individual. The disclosure also relates to a method for the treatment of an individual suffering from a disease associated with an over-active immune response, said method comprising administering to the individual in need thereof a low affinity EGF-R signalling ligand.